The cost and purchase precautions for treating lung cancer with Ripotinib

Repotrectinib (Repotrectinib), as a targeted drug against ROS1 kinase, is mainly used to treat ROS1-positive non-small cell lung cancer (NSCLC) and has shown significant efficacy. This drug effectively prevents the growth and metastasis of cancer cells by specifically inhibiting ROS1 protein and other factors that promote cancer cell growth, bringing new hope to patients.

According to the recommended medication regimen, patients need to take 160 mg once a day (i.e. four 40 mg capsules), which can be increased to 160 mg twice a day after 14 days. From this calculation, patients need approximately 184 40 mg capsules in one month (based on 30 days), and usually need to purchase three boxes of reprotinib capsules (60 capsules per box).

In terms of cost, there are large differences in prices due to different drug versions and purchase channels. In the international market, the original drug, Ripotinib capsules produced by Bristol-Myers Squibb, is relatively expensive, with a box of 40 mg * 120 capsules priced at about 140,000 yuan. Therefore, according to the above-mentioned medication plan, the cost of one month's original drug will be very high, which will put a lot of financial pressure on many patients.

In comparison, the generic version of repotinib capsules launched by Laos Lucius Pharmaceutical Company has a more price advantage. A box of 40 mg * 60 capsules sells for only more than 3,000 yuan. By choosing this version, the patient's monthly drug cost will be significantly reduced, making it more acceptable to ordinary patients.

When purchasing repotinib, patients and their families should pay attention to the following points:

1. Choose formal channels: Be sure to purchase from trustworthy formal channels to avoid the risk of obtaining fake and shoddy products.

2. Verify drug information: Carefully check drug packaging, labels, production date, expiry date, manufacturer and other information to ensure consistency with official information.

3. Consult professionals: Before purchasing, it is best to consult a doctor or pharmacist to understand the version and dosage of the drug that is most suitable for you to ensure the safety and effectiveness of the medication.

Overall, repotinib provides a new treatment option for patients with ROS1-positive non-small cell lung cancer. When purchasing, patients should choose formal channels, verify drug information, and consult professionals to ensure the safety and economy of medication. At the same time, reasonable selection of suitable drug versions and purchase methods based on personal financial status and needs are issues that patients and their families need to seriously consider.

References:

https://www.drugs.com/augtyro.html